Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma

BACKGROUND: The present study aimed to investigate the impact of pre-sarcopenia on the prognosis of patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. METHODS: We enrolled 214 patients (71 ± 10 years old; 166 men and 48 women; 90% Child–Pugh grade A and 10% Child–Pugh grad...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Hitomi, Kurosaki, Masayuki, Nakanishi, Hiroyuki, Takahashi, Yuka, Itakura, Jun, Tsuchiya, Kaoru, Yasui, Yutaka, Tamaki, Nobuharu, Takaura, Kenta, Komiyama, Yasuyuki, Higuchi, Mayu, Kubota, Youhei, Wang, Wann, Okada, Mao, Enomoto, Nobuyuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005492/
https://www.ncbi.nlm.nih.gov/pubmed/29912922
http://dx.doi.org/10.1371/journal.pone.0198812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005492/
https://www.ncbi.nlm.nih.gov/pubmed/29912922
http://dx.doi.org/10.1371/journal.pone.0198812

Ejemplares similares